High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.
This phase 3 GEM12 trial evaluated long-term outcomes of autologous stem cell transplantation (ASCT) conditioning with b...
Emerging Significance and Implications of a Durable Complete Molecular Remission in the Treatment of Polycythemia Vera.
- Post category:Hematologic Cancers
- Reading time:1 min read
This publication reviews advances in the management of polycythemia vera (PV), emphasizing the importance of targeting t...
Overcoming resistance to anti-PD-L1 immunotherapy: mechanisms, combination strategies, and future directions.
- Post category:Hematologic Cancers
- Reading time:1 min read
This publication reviews the complex role of PD-L1 in cancer immunotherapy, focusing on its regulation, interaction with...
Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).
- Post category:Hematologic Cancers
- Reading time:1 min read
This randomized study evaluated pomalidomide, cyclophosphamide, dexamethasone (PCD) versus pomalidomide and dexamethason...
Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation.
- Post category:Hematologic Cancers
- Reading time:1 min read
This publication reviews recent advances in the prevention and treatment of cytomegalovirus (CMV) infection in solid org...
Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study.
- Post category:Hematologic Cancers
- Reading time:1 min read
This dual-center retrospective study evaluated survival outcomes for adolescents and young adults (ages 15-40) with acut...